美國居民不適用 XM 服務。

Guardian Pharmacy targets up to $974 mln valuation in US IPO



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Guardian Pharmacy targets up to $974 mln valuation in US IPO</title></head><body>

Adds background and details on results in paragraphs 4-11

Sept 16 (Reuters) -Guardian Pharmacy Services said on Monday it was targeting a valuation as much as $973.5 million in its initial public offering in the United States.

Expectations of an imminent interest rate cut by the U.S. Federal Reserve are encouraging more companies to press ahead with their listing plans.

Guardian Pharmacy is aiming to raise as much as $108 million by offering 6.75 million shares at a price range of $14 to $16 each.

Founded in 2004, the Atlanta-based company provides pharmacy services to long-term health care facilities in the United States. It owns 50 pharmacies and serves 174,000 residents across 36 states.

The company counts pharmacy services providers Omnicare, PharMerica, PharmCareUSA and Polaris Pharmacy Services among its competitors.

Guardian Pharmacy's revenue jumped to $575.4 million in the six months ended June 30, compared with $502.4 million in the same period in 2023.

More than two-thirds of Guardian Pharmacy's annual revenue over the past three years was from residents of assisted living facilities and behavioral health facilities and group homes, the company said.

The company earned $22.9 million in the first half of this year, compared with $30.2 million in the same period in 2023.

Guardian Pharmacy counts investment firms Bindley Capital Partners and Cardinal Equity Partners among its backers.

William Bindley serves as the chairman of Guardian Pharmacy. He was the founder and CEO of pharmaceutical distribution firm Bindley Western, which was acquired by Cardinal Health CAH.N in a $2.1 billion deal in 2001.

Guardian Pharmacy, which will use a portion of the IPO proceeds to lower debt, plans to list on the New York Stock Exchange under the symbol "GRDN".

Raymond James, Truist Securities and Stephens Inc are the underwriters for the offering.



Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Shounak Dasgupta

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明